Citation: Haichao Zhu, Meihua Liu, Haiyan Li, Ting Guan, Qi Zhang, Yang Chen, Yingxiang Liu, Rolf R. Hartmann, Lina Yin, Qingzhong Hu. Design, synthesis and biological evaluation of pyridyl substituted benzoxazepinones as potent and selective inhibitors of aldosterone synthase[J]. Chinese Chemical Letters, ;2021, 32(7): 2327-2332. doi: 10.1016/j.cclet.2020.11.021 shu

Design, synthesis and biological evaluation of pyridyl substituted benzoxazepinones as potent and selective inhibitors of aldosterone synthase

Haichao Zhu ^{a, 1} ,
Meihua Liu ^{a, 1} ,
Haiyan Li ^a ,
Ting Guan ^a ,
Qi Zhang ^a ,
Yang Chen ^a ,
Yingxiang Liu ^a ,
Rolf R. Hartmann ^b ,
Lina Yin ^{a, *,} ,
Qingzhong Hu ^{a, *,}

a.
School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 51006, China
b.
Pharmaceutical and Medicinal Chemistry, Saarland University, Campus C2.3, D-66123, Saarbrücken, Germany

linayin@gzucm.edu.cn

huqqzh@gzucm.edu.cn

Received Date: 30 August 2020
Revised Date: 2 October 2020
Accepted Date: 10 November 2020
Available Online: 10 November 2020

Figures(3)

Exorbitant aldosterone is closely associated with various severe diseases, including congestive heart failure and chronic kidney disease. As aldosterone synthase is the pivotal enzyme in aldosterone biosynthesis, its inhibition constitutes a promising treatment for these diseases. Via a structure-based approach, a series of pyridyl substituted 3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-ones were designed as inhibitors of aldosterone synthase. Six compounds (5j, 5l, 5m 5w, 5x and 5y) distinguished themselves with potent inhibition (IC₅₀ < 100 nmol/L) and high selectivity over homogenous 11β-hydroxylase. As the most promising compound, 5x exhibited an IC₅₀ of 12 nmol/L and an excellent selectivity factor (SF) of 157, which are both superior to those of the reference fadrazole (IC₅₀=21 nmol/L, SF=7). Importantly, 5x showed no inhibition against steroidogenic CYP17, CYP19 and a panel of hepatic CYP enzymes indicating an outstanding safety profile. As it manifested satisfactory pharmacokinetic properties in rats, compound 5x was considered as a drug candidate for further development.
- Aldosterone synthase,
- Selective inhibitors,
- Benzoxazepinones,
- Heart failure,
- Renal diseases
1. [1]
  J.M. Luther, Curr. Opin. Nephrol. Hypertens. 25 (2016) 16-21. doi: 10.1097/MNH.0000000000000189
2. [2]
  A. Cannavo, A. Elia, D. Liccardo, G. Rengo, W.J. Koch, Vitam. Horm. 109 (2019) 387-406. doi: 10.1016/bs.vh.2018.09.005
3. [3]
  A. Shrestha, R.C. Che, A.H. Zhang, Adv. Exp. Med. Biol. 1165 (2019) 325-346. doi: 10.1007/978-981-13-8871-2_15
4. [4]
  F. Zannad, W. Gattis Stough, P. Rossignol, et al., Eur. Heart J. 33 (2012) 2782-2795. doi: 10.1093/eurheartj/ehs257
5. [5]
  N. Wan, A. Rahman, A. Nishiyama, J. Hum. Hypertens. 35 (2021) 148–156. doi: 10.1038/s41371-020-0377-6
6. [6]
  R. Gros, Q. Ding, L.A. Sklar, et al., Hypertension 57 (2011) 442-451. doi: 10.1161/HYPERTENSIONAHA.110.161653
7. [7]
  M. Packer, Circulation 137 (2018) 1614-1631. doi: 10.1161/circulationaha.117.032474
8. [8]
  Q. Hu, L. Yin, R.W. Hartmann, J. Med. Chem. 57 (2014) 5011-5022. doi: 10.1021/jm401430e
9. [9]
  M. Voets, I. Antes, C. Scherer, et al., J. Med. Chem. 48 (2005) 6632-6642. doi: 10.1021/jm0503704
10. [10]
  L. Yin, Q. Hu, J. Emmerich, et al., J. Med. Chem. 57 (2014) 5179-5189. doi: 10.1021/jm500140c
11. [11]
  Q. Hu, L. Yin, A. Ali, et al., J. Med. Chem. 58 (2015) 2530-2537. doi: 10.1021/acs.jmedchem.5b00079
12. [12]
  N. Strushkevich, A.A. Gilep, L. Shen, et al., Mol. Endocrinol. 27 (2013) 315-324. doi: 10.1210/me.2012-1287
1. [1]
  Yue Xu , Lingzhi Wang , Liu Yang , Renliang Xue , Haowen Zhu , Qifeng Liu , Xueqi Lv , Ruiping Zhang , Jun Tu , Qingce Zang , Yinghong Wang . Spatial metabolomics combined with transcriptomics to reveal heterogeneous metabolism and drug response in the heart of rats with heart failure. Chinese Chemical Letters, 2025, 36(7): 110958-. doi: 10.1016/j.cclet.2025.110958
2. [2]
  Han Yuan , Fengcai Zhang , Hongzhe Huang , Jiafei Wu , Yi Yang , Wanyi Huang , Dongjing Yang , Zhuoming Li , Zhe Li , Ling Huang , Yi-You Huang , Hai-Bin Luo , Lei Guo . Discovery of 3-trifluoromethyl-substituted pyrazoles as selective phosphodiesterase 10A inhibitors for orally attenuating isoprenaline-induced cardiac hypertrophy. Chinese Chemical Letters, 2025, 36(4): 109965-. doi: 10.1016/j.cclet.2024.109965
3. [3]
  Jing Guo , Zhi-Guo Lu , Rui-Chen Zhao , Bao-Ku Li , Xin Zhang . Nucleic acid therapy for metabolic-related diseases. Chinese Chemical Letters, 2025, 36(3): 109875-. doi: 10.1016/j.cclet.2024.109875
4. [4]
  Yuanyi Zhou , Lili Wang , Li Chen , Qingbing Zha , Yu Meng , Mingshan Zhu . Functional inorganic nanomaterials for renal cell carcinoma treatment: Advancements and trends. Chinese Chemical Letters, 2025, 36(12): 110994-. doi: 10.1016/j.cclet.2025.110994
5. [5]
  Lian Jin , Juan Zhang , Libo Nie , Yan Deng , Ghulam Jilany Khana , Nongyue He . Chitosan nanoparticles act as promising carriers of microRNAs to brain cells in neurodegenerative diseases. Chinese Chemical Letters, 2025, 36(10): 110774-. doi: 10.1016/j.cclet.2024.110774
6. [6]
  Li Li , Jiale Wen , Xiaojun Zhang , Shuwen Fu , Zixuan Chen , Kai Huang , Luyue Fang , Tinghe Zhao , Peipei Zhang , Xingshu Li . A near-infrared naphthalocyanine photosensitizer with superior light absorption and renal clearance for type-Ⅰ photodynamic and photothermal combination therapy. Chinese Chemical Letters, 2025, 36(6): 110290-. doi: 10.1016/j.cclet.2024.110290
7. [7]
  Feifei Wang , Hang Yao , Xinyue Wu , Yijian Tang , Yang Bai , Hui Chong , Huan Pang . Metal–organic framework and its composites modulate macrophage polarization in the treatment of inflammatory diseases. Chinese Chemical Letters, 2024, 35(5): 108821-. doi: 10.1016/j.cclet.2023.108821
8. [8]
  Wenfeng Shao , Chuanlin Li , Chenggang Wang , Guangsen Du , Shunshun Zhao , Guangmeng Qu , Yupeng Xing , Tianshuo Guo , Hongfei Li , Xijin Xu . Stabilization of zinc anode by trace organic corrosion inhibitors for long lifespan. Chinese Chemical Letters, 2025, 36(3): 109531-. doi: 10.1016/j.cclet.2024.109531
9. [9]
  Lu-Lu He , Lan-Tu Xiong , Xin Wang , Yu-Zhen Li , Jia-Bao Li , Yu Shi , Xin Deng , Zi-Ning Cui . Application of inhibitors targeting the type III secretion system in phytopathogenic bacteria. Chinese Chemical Letters, 2025, 36(4): 110044-. doi: 10.1016/j.cclet.2024.110044
10. [10]
  Shiqi Xu , Zi Ye , Shuang Shang , Fengge Wang , Huan Zhang , Lianguo Chen , Hao Lin , Chen Chen , Fang Hua , Chong-Jing Zhang . Pairs of thiol-substituted 1,2,4-triazole-based isomeric covalent inhibitors with tunable reactivity and selectivity. Chinese Chemical Letters, 2024, 35(7): 109034-. doi: 10.1016/j.cclet.2023.109034
11. [11]
  Mianling Yang , Meehyein Kim , Peng Zhan . Modular miniaturized synthesis and in situ biological evaluation facilitate rapid discovery of potent MraY inhibitors as antibacterial agents. Chinese Chemical Letters, 2025, 36(2): 110455-. doi: 10.1016/j.cclet.2024.110455
12. [12]
  Chunyu Yan , Qinglong Qiao , Wei Zhou , Xuelian Zhou , Yonghui Chen , Lu Miao , Zhaochao Xu . FRET-based in vitro assay for rapid detecting of SARS-CoV-2 entry inhibitors. Chinese Chemical Letters, 2025, 36(5): 110258-. doi: 10.1016/j.cclet.2024.110258
13. [13]
  Zhaoyong Kang , Shen Li , Yan Li , Jingfeng Song , Yangrui Peng , Yihua Chen . Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024). Chinese Chemical Letters, 2025, 36(7): 110447-. doi: 10.1016/j.cclet.2024.110447
14. [14]
  Yi-You Huang , Xiang Luo , Kai Zhang , Yulan Liang , Furong Zhang , Guochao Liao , Shenghong Xie , Pei-Luo Huang , Siyu Hou , Qian Zhou , Yong Zou , Hai-Bin Luo . Structure-based optimization of isoaurostatin as novel PDE4 inhibitors with anti-fibrotic effects. Chinese Chemical Letters, 2025, 36(8): 110586-. doi: 10.1016/j.cclet.2024.110586
15. [15]
  Yifan Feng , Chengjuan Chen , Anqi Shao , Qingyang Zhang , Lan Sun , Hai-Yu Hu , Tiantai Zhang . Recent advances in interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors and PROTACs. Chinese Chemical Letters, 2025, 36(12): 110963-. doi: 10.1016/j.cclet.2025.110963
16. [16]
  Jian Song , Shenghui Wang , Qiuge Liu , Xiao Wang , Shuo Yuan , Hongmin Liu , Saiyang Zhang . N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters, 2025, 36(2): 109678-. doi: 10.1016/j.cclet.2024.109678
17. [17]
  Yuan Xiong , Lan-Hui Qin , Bei Zhao , Lei-Zhi Xu , Yu-Fan Fan , Tian Tian , Hai-Rong Zeng , Ting Liu , Jian Huang , Jian-Ming Sun , Zhen-Hao Tian , Guang-Bo Ge . Structure-based design and development of halogenated-naphthalimides as potent hCYP1B1 inhibitors for overcoming paclitaxel resistance. Chinese Chemical Letters, 2025, 36(11): 110812-. doi: 10.1016/j.cclet.2024.110812
18. [18]
  Kezhen Qi , Shu-yuan Liu , Ruchun Li . Selective dissolution for stabilizing solid electrolyte interphase. Chinese Chemical Letters, 2024, 35(5): 109460-. doi: 10.1016/j.cclet.2023.109460
19. [19]
  Cheng-Da Zhao , Huan Yao , Shi-Yao Li , Fangfang Du , Li-Li Wang , Liu-Pan Yang . Amide naphthotubes: Biomimetic macrocycles for selective molecular recognition. Chinese Chemical Letters, 2024, 35(4): 108879-. doi: 10.1016/j.cclet.2023.108879
20. [20]
  Jiaqi Jia , Kathiravan Murugesan , Chen Zhu , Huifeng Yue , Shao-Chi Lee , Magnus Rueping . Multiphoton photoredox catalysis enables selective hydrodefluorinations. Chinese Chemical Letters, 2025, 36(2): 109866-. doi: 10.1016/j.cclet.2024.109866

Get Citation

PDF

XML

Metrics

PDF Downloads(11)
Abstract views(1615)
HTML views(172)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142